intranasal betahistine

Auris Medical Provides Update on Phase 2 Trial of AM-125 for the Treatment of Acute Peripheral Vertigo

April 3, 2020

https://www.globenewswire.com/news-release/2020/04/03/2011729/0/en/Auris-Medical-Provides-Update-on-Intranasal-Betahistine-Development-Program.html

Auris Medical Provides Update on Intranasal Betahistine Development Program

March 5, 2020

https://finance.yahoo.com/news/auris-medical-provides-ongoing-clinical-133000473.html

Auris Medical Provides Update on Ongoing Clinical Trials with Intranasal Betahistine